Literature DB >> 6226829

Hematoporphyrin derivative: quantitative uptake in dimethylhydrazine-induced murine colorectal carcinoma.

M V Agrez, R E Wharen, R E Anderson, E R Laws, D M Ilstrup, D A Cortese, R G Shorter, M M Lieber.   

Abstract

The selective affinity of hematoporphyrin derivative (HpD) for dimethyl-hydrazine-induced colorectal malignancies in mice was evaluated both visually and by a quantitative microfluorescent photometric technique. A significant correlation was found between higher concentrations of HpD in colon biopsies determined by microfluorescence spectroscopy and the presence of carcinoma cells in these biopsies as identified by histologic examination. Visual inspection of the gross fluorescence of tumor-bearing colons in this experimental model, however, was not helpful in differentiating malignant from nonmalignant tissue. The implications of this study regarding the clinical application of HpD tumor fluorescence for the detection of colorectal carcinoma are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6226829     DOI: 10.1002/jso.2930240305

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Photodynamic therapy in gastroenterology.

Authors:  S G Bown; C E Millson
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas.

Authors:  S G Smith; J Bedwell; A J MacRobert; M H Griffiths; S G Bown; M R Hetzel
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

Review 3.  Photodynamic therapy for colorectal disease.

Authors:  H Barr; S G Bown; N Krasner; P B Boulos
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

4.  Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma.

Authors:  C J Tralau; A J MacRobert; P D Coleridge-Smith; H Barr; S G Bown
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

5.  Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.

Authors:  C S Loh; A J MacRobert; J Bedwell; J Regula; N Krasner; S G Bown
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.